From 1st to 5th Dec 2024, the Radiological Society of North America (RSNA) grandly opened in Chicago, USA, attracting more than 60,000 medical radiology practitioners from nearly 100 countries around the world to participate in the grand event to share the latest scientific research results and look forward to the future trends of the discipline.
Liverscan debuts at RSNA
As the top event in the field of medical radiology imaging, RSNA has always led the development direction of global radiology imaging, and tens of thousands of attendees can gain a comprehensive insight into the latest developments and cutting-edge explorations in the field of radiology.
At this event, Eieling Technology made a stunning appearance with its self-developed portable liver bomb analyzer Liverscan, which attracted enthusiastic attention and strong interest from visitors from all over the world.
Independent research and development to break the technology monopoly
Liverscan is a breakthrough that perfectly integrates Two sophisticated technologies, Transient Elastography Imaging (TE) and Ultrasonic real-time imaging guide B, which are incorporated into the wireless probe. The test only takes one minute to complete, achieving a non-invasive, painless, fast, and accurate liver health assessment, which greatly improves clinical testing efficiency.
At the same time, the significant reduction in cost will help Liverscan be widely used in more medical scenarios and effectively alleviate the problem of uneven distribution of medical resources.
Strengthen cooperation to protect liver health
This RSNA event is not only an important demonstration of the strength of Eieling Technology, but also a high degree of recognition and affirmation of its innovative capabilities. Liverscan breaks the technical barriers of foreign brands and stands out among many products with its efficient and accurate detection capabilities, providing healthcare providers with trustworthy liver health diagnostic solutions.
Looking forward to the future, Eieling Technology will continue to uphold the corporate spirit of “innovation-led, win-win collaboration, and responsibility”, work hard and continue to explore new technologies for liver disease diagnosis. At the same time, the company will further strengthen international cooperation and exchanges, and join hands with global experts and colleagues to jointly promote the progress and development of liver diagnostic technology and contribute more to human health.
